Shares of Profound Medical Corp. (TSE:PRN – Get Rating) traded up 0.8% during trading on Thursday . The company traded as high as C$9.52 and last traded at C$9.37. 16,234 shares traded hands during mid-day trading, a decline of 69% from the average session volume of 51,556 shares. The stock had previously closed at C$9.30.
Separately, Raymond James reiterated a “buy” rating and set a C$23.00 price objective on shares of Profound Medical in a research note on Tuesday, February 22nd.
The company has a quick ratio of 16.50, a current ratio of 18.56 and a debt-to-equity ratio of 1.71. The stock’s 50 day moving average price is C$11.21 and its 200-day moving average price is C$13.21. The stock has a market capitalization of C$194.71 million and a P/E ratio of -4.87.
About Profound Medical (TSE:PRN)
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland.
- There’s An Institutional Floor In Keurig Dr. Pepper
- Ford Falls Despite Optimistic Outlook
- Harley-Davidson Skids Into A Buying Opportunity
- Facebook (NASDAQ: FB) Soars And Wall Street Delights
- Automatic Data Processing Is Ready To Scale New Heights
Receive News & Ratings for Profound Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Profound Medical and related companies with MarketBeat.com's FREE daily email newsletter.